What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Cancer
- Gene
Lisa M. Sullivan mostly deals with Internal medicine, Framingham Risk Score, Endocrinology, Risk factor and Framingham Heart Study.
The various areas that Lisa M. Sullivan examines in her Internal medicine study include Diabetes mellitus and Cardiology.
Her Framingham Risk Score study incorporates themes from Relative risk, Demography, Proportional hazards model and Cohort study.
Her research investigates the link between Endocrinology and topics such as Offspring that cross with problems in Impaired glucose tolerance, Glycemic and Physiology.
Her Risk factor research integrates issues from Schizophrenia, Antipsychotic, Abortion, Epidemiology and Surgery.
Lisa M. Sullivan has researched Framingham Heart Study in several fields, including Regression analysis, Multivariate analysis, Heart disease and Multivariate statistics.
Her most cited work include:
- Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. (1863 citations)
- Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. (1863 citations)
- Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus (1509 citations)
What are the main themes of her work throughout her whole career to date?
Her primary scientific interests are in Internal medicine, Framingham Heart Study, Endocrinology, Framingham Risk Score and Cardiology.
Her Internal medicine study frequently draws connections between related disciplines such as Diabetes mellitus.
Her Framingham Heart Study research is multidisciplinary, relying on both Epidemiology, Hazard ratio, Confidence interval, Proportional hazards model and Heart disease.
Her work in the fields of Metabolic syndrome, Insulin resistance, Adipokine and Cholesterol overlaps with other areas such as Asymmetric dimethylarginine.
Her Framingham Risk Score research includes themes of Offspring, Gerontology, Cohort study, Demography and Cohort.
She interconnects Stroke and Surgery in the investigation of issues within Risk factor.
She most often published in these fields:
- Internal medicine (42.43%)
- Framingham Heart Study (24.33%)
- Endocrinology (24.33%)
What were the highlights of her more recent work (between 2013-2021)?
- Internal medicine (42.43%)
- Framingham Heart Study (24.33%)
- Endocrinology (24.33%)
In recent papers she was focusing on the following fields of study:
Her scientific interests lie mostly in Internal medicine, Framingham Heart Study, Endocrinology, Pathology and Hazard ratio.
Internal medicine and Cardiology are frequently intertwined in her study.
The Framingham Heart Study study combines topics in areas such as Statistics, Cohort study, Confidence interval and Risk factor.
Her research in Risk factor focuses on subjects like Stroke, which are connected to Type 2 Diabetes Mellitus.
Her Endocrinology research includes elements of Offspring, Subclinical infection and Cohort.
Her Hazard ratio study combines topics from a wide range of disciplines, such as Epidemiology and Proportional hazards model.
Between 2013 and 2021, her most popular works were:
- Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant. (326 citations)
- A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas (93 citations)
- Revised Framingham Stroke Risk Profile to Reflect Temporal Trends. (75 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
